Brand family
Breztri
Budesonide, Formoterol and Glycopyrrolate · AstraZeneca Pharmaceuticals
United States
- Presentations
- 2
- Markets
- 1
Breztri is a brand of Budesonide, Formoterol and Glycopyrrolate marketed by AstraZeneca Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Budesonide, Formoterol and Glycopyrrolate
- Brand owner
- AstraZeneca Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 160 mcg/4.8 mcg/18 mcg inhaler, 160 mcg/4.8 mcg/9 mcg inhaler
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Breztri 160 mcg/4.8 mcg/18 mcg inhalerInhalation | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Breztri 160 mcg/4.8 mcg/9 mcg inhalerInhalation | AstraZeneca Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Breztri
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.